Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

News: Novavax (NVAX) is in the spotlight as a deal is being discussed. The company's stock has been affected by public health policies, but there is optimism around its protein-based flu application. Additionally, there are rumors about RFK purchasing a house near a former FDA director's neighborhood. Despite some uncertainty, Novavax remains a key player in the gene therapy field. Sri Lanka is also remaining vigilant against the Nipah virus amidst record tourist arrivals.